Mayo, Muiz U.
HRN: 20-92-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/17/2025
11/24/2025
ORAL
8ml
Q8
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes